Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas

BACKGROUND: The updated American Joint Committee on Cancer (AJCC) staging criteria for melanoma remain unable to identify high‐risk stage I tumour subsets. OBJECTIVES: To determine the utility of epidermal autophagy and beclin 1 regulator 1 (AMBRA1)/loricrin (AMLo) expression as a prognostic biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, R., Tang, D., Nasr, B., Greenwood, A., McConnell, A., Anagnostou, M.E., Elias, M., Verykiou, S., Bajwa, D., Ewen, T., Reynolds, N.J., Barrett, P., Carling, E., Watson, G., Armstrong, J., Allen, A.J., Horswell, S., Labus, M., Lovat, P.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973157/
https://www.ncbi.nlm.nih.gov/pubmed/31056744
http://dx.doi.org/10.1111/bjd.18086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973157/
https://www.ncbi.nlm.nih.gov/pubmed/31056744
http://dx.doi.org/10.1111/bjd.18086

Ejemplares similares